tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

APGE Stock Latest News

Buy Rating Affirmed for Apogee Therapeutics: Promising Developments in Inflammatory Disease Treatments
RatingsBuy Rating Affirmed for Apogee Therapeutics: Promising Developments in Inflammatory Disease Treatments
13d ago
APGE
Oruka Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe Fly
Oruka Therapeutics initiated with an Outperform at Wolfe Research
19d ago
APGE
ORKA
Apogee Therapeutics Advances APG777 in Key Phase 2 Trial
PremiumCompany Announcements
Apogee Therapeutics Advances APG777 in Key Phase 2 Trial
20d ago
8K
APGE
Apogee announces first patient dosed in Part B of Phase 2 APEX trial
PremiumThe Fly
Apogee announces first patient dosed in Part B of Phase 2 APEX trial
20d ago
APGE
Short Report: Spike in bearish bets on Lovesac pays off
PremiumThe Fly
Short Report: Spike in bearish bets on Lovesac pays off
2M ago
GES
HPK
Apogee Therapeutics Advances Clinical Trials for APG333
PremiumCompany AnnouncementsApogee Therapeutics Advances Clinical Trials for APG333
2M ago
8K
APGE
Apogee Therapeutics first participants dosed in Phase 1 trial of APG333
Premium
The Fly
Apogee Therapeutics first participants dosed in Phase 1 trial of APG333
2M ago
APGE
Apogee Therapeutics price target raised to $90 from $87 at Wedbush
Premium
The Fly
Apogee Therapeutics price target raised to $90 from $87 at Wedbush
3M ago
APGE
Apogee Therapeutics Advances in I&I Disease Treatments
PremiumCompany Announcements
Apogee Therapeutics Advances in I&I Disease Treatments
3M ago
8K
APGE
Apogee Therapeutics highlights progress at 2024 Inaugural R&D Day
PremiumThe Fly
Apogee Therapeutics highlights progress at 2024 Inaugural R&D Day
3M ago
APGE
Apogee Therapeutics plans to take combination approach to AD
PremiumThe Fly
Apogee Therapeutics plans to take combination approach to AD
3M ago
APGE
Apogee Therapeutics price target raised to $110 from $95 at Guggenheim
PremiumThe Fly
Apogee Therapeutics price target raised to $110 from $95 at Guggenheim
3M ago
APGE
Apogee initiated with a Buy at Canaccord on APG777 ‘blockbuster potential’
PremiumThe FlyApogee initiated with a Buy at Canaccord on APG777 ‘blockbuster potential’
3M ago
APGE
Apogee Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
Apogee Therapeutics initiated with a Buy at Canaccord
3M ago
APGE
Apogee Therapeutics Highlights Pipeline Progress and Financials
Premium
Company Announcements
Apogee Therapeutics Highlights Pipeline Progress and Financials
3M ago
APGE
Apogee reports Q3 EPS, expects cash to fund operations into Q1 of 2028
PremiumThe Fly
Apogee reports Q3 EPS, expects cash to fund operations into Q1 of 2028
3M ago
APGE
Apogee Therapeutics, Inc. (APGE) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Apogee Therapeutics, Inc. (APGE) Q3 Earnings Cheat Sheet
4M ago
APGE
Apogee Therapeutics price target raised to $100 from $81 at BTIG
PremiumThe Fly
Apogee Therapeutics price target raised to $100 from $81 at BTIG
4M ago
LLY
APGE
Apogee Therapeutics Unveils Promising Phase 1 Trial Results
PremiumCompany Announcements
Apogee Therapeutics Unveils Promising Phase 1 Trial Results
4M ago
8K
APGE
Apogee Therapeutics announces updated results from Phase 1 trial of APG777
PremiumThe FlyApogee Therapeutics announces updated results from Phase 1 trial of APG777
4M ago
APGE
Apogee Therapeutics names Jeff Hartness as Chief Commercial Officer
Premium
The Fly
Apogee Therapeutics names Jeff Hartness as Chief Commercial Officer
6M ago
APGE
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
Premium
The Fly
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
6M ago
APGE
SYRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >